2018 American Transplant Congress

Monday, June 4, 2018

2:42pm-2:54pm

QPI-1002, a siRNA Targeting p53: Improvement in Outcomes Following Acute Kidney Injury (AKI): Cardiac Surgery to AKI Donors

J. Tchervenkov,² E. Squiers,¹ R. Stratta,³ D. Odenheimer,² D. Rothenstein,² QPI-1002 DGF Study Group.

Concurrent Session: Ischemia Reperfusion Injury: Time to Change the Paradigm?  •  Room 6B

2:42pm-2:54pm

Robotic Pancreas Transplantation in Obese Recipients: Preliminary Results

M. Spaggiari,¹ C. Di Bella,¹ P. Di Cocco,¹ F. Gheza,¹ E. Benedetti,¹ I. Tzvetanov,¹ J. Oberholzer.²

Concurrent Session: Surgical Issues (Open, Minimally Invasive): All Organs  •  Room 2AB

2:42pm-2:54pm

The Impact of Donor Specific Alloantibodies on Long-Term Outcomes of Liver Re-Transplantation

Q. Xu,¹ A. Skaro,² V. McAlister.²

Concurrent Session: Liver Retransplantation and Other Complications  •  Room 6A

2:42pm-2:54pm

Tocilizumab Stabilizes Renal Function in Kidney Transplant Recipients with Chronic Active Antibody Mediated Rejection (CAAMR)

S. Patel, S. Mohan, H. Fernandez, I. Batal, L. Ratner, J. Crew.

Concurrent Session: Kidney Chronic Antibody Mediated Rejection  •  Room 4B

2:42pm-2:54pm

Validation of a Transplant Knowledge Quiz and Its Impact on Outcomes in Kidney Transplant Recipients

H. Corbo, N. Patel, N. Pilch, V. Rohan, J. Fleming, T. Harrison, J. Hardcopf, B. O'Brien, C. Perez, P. Baliga, H. Meadows, D. Taber.

Concurrent Session: Kidney Psychosocial - 2  •  Room 210

2:54pm-3:06pm

Central Role of Mef2 Transcription Factors in Regulation of Foxp3 Expression and Treg Function

A. Samanta,¹ L. Wang,¹ R. Han,¹ W. Hancock.^1,2

Concurrent Session: Novel Regulatory Pathways in Tolerance  •  Room 606/607

2:54pm-3:06pm

Dependency on CD4 T Cells, Foreign Protein, and CD22 for Generation of Antibody Response to Non-Self Blood Group A-Antigen in a Mouse Model

I. Adam, B. Motyka, K. Tao, L. West.

Concurrent Session: B-cell / Antibody  •  Room 615/616/617

2:54pm-3:06pm

Extended Experience Using Tocilizumab (Anti-IL6R, TCZ) for the Treatment of Chronic Antibody Mediated Rejection (CABMR)

J. Choi,¹ O. Aubert,² S. Louie,¹ N. Ammerman,¹ A. Vo,¹ A. Peng,¹ E. Huang,¹ R. Najjar,¹ D. Puliyanda,¹ S. Sethi,¹ M. Haas,¹ K. Lim,¹ A. Loupy,² S. Jordan.¹

Concurrent Session: Kidney Chronic Antibody Mediated Rejection  •  Room 4B

2:54pm-3:06pm

First Birth after Uterus Transplant in the US

L. Johannesson, R. Gunby, Jr., T. Anthony, G. McKenna, E. Koon, A. Warren, G. dePrisco, J. Mitchell, J. Putman, K. Wallis, G. Klintmalm, G. Testa.

Concurrent Session: VCA  •  Room 303

2:54pm-3:06pm

Geographic Variation in the Survival Benefit of Heart Transplantation

W. Parker,¹ R. Gibbons,¹ M. Churpek,¹ A. Anderson.²

Concurrent Session: Location, Location, Allocation in Heart Transplantation  •  Room 4C-3